IDbyDNA Shares Insights on Role of Metagenomics for Tracking COVID-19 on New Illumina Podcast
Share Article
Metagenomics Innovator Featured on New Series about Role of Genomics for Managing Global Pandemics
Medicine is on the cusp of the most dramatic change in infectious disease work since the discovery of antibiotics. SAN FRANCISCO (PRWEB) April 09, 2021 Today, IDbyDNA, the company revolutionizing the use of metagenomics to improve health by decoding the unknown, is being featured on two episodes of the new Illumina, Inc. (Nasdaq: ILMN) podcast about the power and promise of genomic sequencing in the face of the COVID-19 pandemic. The U.S. is nearing a fourth surge with the average number of COVID-19 cases rising 20 percent in two weeks to 65,000 per day and variants discovered in all 50 states. On this podcast, IDbyDNA Chief Medical Officer and Co-Founder Dr. Robert Schlaberg and Head of Medical Affairs Dr. L
San Francisco, CA (PRWEB) February 08, 2021 Today, IDbyDNA, the company revolutionizing the use of metagenomics to improve health by decoding the unknown,
Dr. Lauge Farnaes
Dr. Lauge Farnaes is Head of Medical Affairs at IDbyDNA, the company revolutionizing the use of metagenomics to improve health by decoding the unknown. IDbyDNA and Illumina, Inc. (Nasdaq: ILMN) recently co-launched a Respiratory Pathogen ID/AMR Target Enrichment Panel for Research Use Only that aims to accelerate and improve testing for infectious diseases. The panel targets more than 280 pathogens and can also detect genes associated with antimicrobial resistance markers, providing insight into how the misuse of antimicrobials can lead to antibiotic resistance.
Dr. Farnaes is board certified in pediatrics, pediatric infectious disease and Pediatric hematology and oncology. He works as an attending physician in the division of pediatric infectious disease at UCSD/Rady children’s hospital. Dr Farnaes did pioneering work in the cost effectiveness of rapid whole genome sequencing for critically ill children and is now working on creating similar evidence for the b